
---
title: Antipsychotics & Antidepressants Cheatsheet
markmap:
  colorFreezeLevel: 6
---

## Antipsychotics

### Mechanism
- D2 Receptor Blockade (Primarily Typical)
- Serotonin 2A (5-HT2A) Blockade (Primarily Atypical)
- Other receptors: H1, Alpha-1, Muscarinic (Contributes to side effects)

### Classes
- **Typical (1st Gen)**
  - High Potency (Haloperidol, Fluphenazine)
    - High EPS risk
    - Less sedation/orthostasis
  - Low Potency (Chlorpromazine, Thioridazine)
    - Low EPS risk
    - High sedation/orthostasis/anticholinergic
- **Atypical (2nd Gen)**
  - Serotonin-Dopamine Antagonists
  - Less EPS risk
  - Higher metabolic risk
  - Examples: Clozapine, Risperidone, Olanzapine, Quetiapine, Ziprasidone, Aripiprazole, Lurasidone

### Key Drugs & Features
- **Clozapine**
  - Most effective for treatment-resistant schizophrenia
  - Risk of Agranulocytosis (requires monitoring - ANC)
  - Myocarditis, Seizures, Sialorrhea, Weight gain
- **Risperidone**
  - High Hyperprolactinemia risk (dose-dependent)
- **Olanzapine**
  - High risk of Weight gain & Metabolic syndrome
  - Sedation
- **Quetiapine**
  - Low EPS risk, good for Parkinson's psychosis
  - Sedation, Orthostatic hypotension, Weight gain
- **Ziprasidone**
  - Lower metabolic risk
  - Risk of QT prolongation (Take with food)
- **Aripiprazole**
  - Partial D2 agonist (less EPS, metabolic)
  - Risk of Akathisia
- **Lurasidone**
  - Lower metabolic risk
  - Take with food

### Side Effects
- **Extrapyramidal Symptoms (EPS)**
  - Acute Dystonia (Early, involuntary muscle contractions)
  - Akathisia (Restlessness)
  - Parkinsonism (Tremor, Rigidity, Bradykinesia)
  - Tardive Dyskinesia (Late, involuntary movements, irreversible)
- **Neuroleptic Malignant Syndrome (NMS)**
  - Fever, Rigidity, Mental status change, Autonomic instability
  - Emergency - Stop drug, Supportive care, Dantrolene/Bromocriptine
- **Metabolic Syndrome**
  - Weight gain, Dyslipidemia, Insulin resistance/Diabetes
  - Monitor BMI, Lipids, Glucose
- **Cardiac**
  - QT Prolongation (Risk of Torsades de Pointes) - Thioridazine, Ziprasidone
- **Endocrine**
  - Hyperprolactinemia (Galactorrhea, Amenorrhea, Sexual dysfunction, Osteoporosis) - Risperidone, typicals
- **Other**
  - Sedation, Orthostatic Hypotension (Alpha-1 blockade)
  - Anticholinergic (Dry mouth, Constipation, Blurred vision)
  - Seizures (Clozapine > Low potency typicals)

## Antidepressants

### Mechanism
- Increase levels of Serotonin (5-HT), Norepinephrine (NE), Dopamine (DA) in synapse

### Classes
- **SSRI (Selective Serotonin Reuptake Inhibitors)**
  - Inhibit SERT
  - First-line for MDD, Anxiety disorders
  - Examples: Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram
- **SNRI (Serotonin-Norepinephrine Reuptake Inhibitors)**
  - Inhibit SERT & NET
  - Examples: Venlafaxine, Duloxetine, Desvenlafaxine, Levomilnacipran
- **TCA (Tricyclic Antidepressants)**
  - Inhibit SERT & NET + block H1, Alpha-1, Muscarinic receptors
  - Risk of Cardiotoxicity, Sedation, Anticholinergic effects
  - Examples: Amitriptyline, Imipramine, Nortriptyline, Clomipramine
- **MAOI (Monoamine Oxidase Inhibitors)**
  - Inhibit MAO-A & MAO-B
  - Risk of Hypertensive crisis with tyramine-rich foods
  - Risk of Serotonin syndrome with other serotonergic drugs
  - Examples: Phenelzine, Tranylcypromine, Isocarboxazid, Selegiline (patch - selective for MAO-B at low doses)
- **Atypicals**
  - Bupropion: NDRI, lowers seizure threshold, good for smoking cessation, less sexual dysfunction
  - Mirtazapine: Alpha-2 antagonist, H1 blockade, Sedation, Weight gain
  - Trazodone: Serotonin modulator, H1 blockade, Alpha-1 blockade, Sedation, Risk of PRIAPISM
  - Vortioxetine: Multimodal (inhibits SERT + receptor modulation)
  - Vilazodone: SPARI (SERT inhibition + partial 5-HT1A agonism)

### Side Effects
- **Serotonin Syndrome**
  - Mental status change (Agitation, Confusion), Autonomic hyperactivity (Fever, Sweating, Tachycardia), Neuromuscular abnormalities (Hyperreflexia, Myoclonus, Rigidity)
  - Risk with combining serotonergic drugs (SSRI+MAOI, SNRI+TCA, Tramadol, Ondansetron, etc.)
  - Emergency - Stop drugs, Supportive care, Benzodiazepines, Cyproheptadine (severe)
- **SSRI/SNRI Specific**
  - GI distress (Nausea, Diarrhea)
  - Sexual dysfunction (Most common reason for discontinuation)
  - Insomnia or Sedation
  - Headache
  - Risk of increased bleeding (especially with NSAIDs/Anticoagulants)
  - Hyponatremia (SIADH)
  - Serotonin Discontinuation Syndrome (Flu-like symptoms, Dizziness, Paresthesias - electric shocks, "brain zaps") - more common with short half-life drugs (Paroxetine, Venlafaxine)
- **TCA Specific**
  - Anticholinergic (Dry mouth, Constipation, Urinary retention, Blurred vision)
  - Sedation
  - Orthostatic Hypotension
  - Cardiotoxicity (QT, QRS widening, arrhythmias) - Major concern in overdose
- **MAOI Specific**
  - Hypertensive Crisis (Interaction with tyramine-rich foods - aged cheese, cured meats, red wine) - Severe headache, Palpitations, Chest pain, Stiff neck
  - Serotonin Syndrome (with other serotonergic agents)
  - Insomnia, Orthostatic Hypotension

### Important INICET Buzzwords
- EPS
- Akathisia
- Dystonia
- Tardive Dyskinesia
- NMS (Neuroleptic Malignant Syndrome)
- Serotonin Syndrome
- Clozapine
- Agranulocytosis
- Metabolic Syndrome
- QT Prolongation
- Hyperprolactinemia
- PRIAPISM
- TCA Overdose (Cardiotoxicity)
- MAOI Hypertensive Crisis
- Tyramine
- Serotonin Discontinuation Syndrome
- Bupropion (Seizure risk)
- Mirtazapine (Sedation, Weight gain)
- Orthostatic Hypotension
- ANC monitoring (Clozapine)
- Cyproheptadine (Serotonin Syndrome Rx)
- Dantrolene/Bromocriptine (NMS Rx)
- Anticholinergics (EPS Rx)
- "Brain zaps" (SSRI Discontinuation)
- SIADH (SSRI)
- Anhedonia
- Avolition
- Alogia
- Affective flattening
- Catatonia


